Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
China
Peking University First Hospital, Beijing, Beijing Municipality Nanjing Drum Tower Hospital, Nanjing, Jiangsu Last updated November 2024